This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Incyte Corporation. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Robert Susick
Introduction
Robert Susick is a notable inventor based in Wilmington, Delaware. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target KRAS activity, which is crucial in cancer treatment.
Latest Patents
Robert Susick holds a patent for quinoline compounds as inhibitors of KRAS. This patent discloses compounds of Formula I, methods for using these compounds to inhibit KRAS activity, and pharmaceutical compositions that include such compounds. These innovations are particularly useful in treating, preventing, or ameliorating diseases associated with KRAS activity, including various forms of cancer.
Career Highlights
Robert Susick is currently employed at Incyte Corporation, a leading biopharmaceutical company. His work focuses on developing innovative therapies that address unmet medical needs, particularly in oncology.
Collaborations
Robert has collaborated with esteemed colleagues such as Qinda Ye and Matthew Mccammant, contributing to the advancement of research and development in their field.
Conclusion
Robert Susick's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions to KRAS inhibitors represent a significant step forward in cancer treatment.